Bionik Laboratories (OTCMKTS:BNKL) Stock Price Passes Above 50-Day Moving Average – Here’s What Happened
by Scott Moore · The Cerbat GemBionik Laboratories Corp. (OTCMKTS:BNKL – Get Free Report) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.00 and traded as high as $0.0001. Bionik Laboratories shares last traded at $0.00, with a volume of 0 shares changing hands.
Bionik Laboratories Trading Down 100.0%
Bionik Laboratories Company Profile
Bionik Laboratories Corp., headquartered in Waltham, Massachusetts, designs, develops and markets robotics-based rehabilitation solutions and assistive devices for patients with neurological and mobility impairments. Its core product portfolio includes the ARKE lower limb exoskeleton for gait training and the InMotion series of upper extremity robotic therapy devices, such as InMotion ARM and InMotion WRIST. These systems leverage sensor-driven feedback and proprietary software to enable clinicians to deliver personalized motor rehabilitation programs.
Founded in 2008, Bionik established a foundation in exoskeleton and robotics technology before expanding its clinical product suite through strategic acquisitions and research collaborations.
Recommended Stories
- Five stocks we like better than Bionik Laboratories
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?